Nkarta
Dr. Scheiner joined RA Capital Management, LLC in 2015 where he is a Principal on the Investment Team. Prior to joining RA Capital, Dr. Scheiner was a Science Officer at the California Institute for Regenerative Medicine. Dr. Scheiner works on both public and private investments and serves as a board director for two other privately-held companies. Dr. Scheiner holds a BS in Molecular Biophysics and Biochemistry from Yale University and a Ph.D. in Neurobiology and Behavior from the University of Washington.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Nkarta
1 followers
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer.